These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9272487)

  • 1. Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide.
    Javitt DC; Sershen H; Hashim A; Lajtha A
    Neuropsychopharmacology; 1997 Sep; 17(3):202-4. PubMed ID: 9272487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous phencyclidine treatment induces schizophrenia-like hyperreactivity of striatal dopamine release.
    Balla A; Koneru R; Smiley J; Sershen H; Javitt DC
    Neuropsychopharmacology; 2001 Aug; 25(2):157-64. PubMed ID: 11425499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of striatal dopamine release by glycine and glycyldodecylamide.
    Javitt DC; Sershen H; Hashim A; Lajtha A
    Brain Res Bull; 2000 Jun; 52(3):213-6. PubMed ID: 10822163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of phencyclidine-induced dopaminergic dysregulation by N-methyl-D-aspartate receptor/glycine-site agonists.
    Javitt DC; Balla A; Burch S; Suckow R; Xie S; Sershen H
    Neuropsychopharmacology; 2004 Feb; 29(2):300-7. PubMed ID: 14560321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse.
    Javitt DC; Frusciante M
    Psychopharmacology (Berl); 1997 Jan; 129(1):96-8. PubMed ID: 9122370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
    Depoortère R; Dargazanli G; Estenne-Bouhtou G; Coste A; Lanneau C; Desvignes C; Poncelet M; Heaulme M; Santucci V; Decobert M; Cudennec A; Voltz C; Boulay D; Terranova JP; Stemmelin J; Roger P; Marabout B; Sevrin M; Vigé X; Biton B; Steinberg R; Françon D; Alonso R; Avenet P; Oury-Donat F; Perrault G; Griebel G; George P; Soubrié P; Scatton B
    Neuropsychopharmacology; 2005 Nov; 30(11):1963-85. PubMed ID: 15956994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative trait loci contributing to phencyclidine-induced and amphetamine-induced locomotor behavior in inbred mice.
    Alexander RC; Wright R; Freed W
    Neuropsychopharmacology; 1996 Nov; 15(5):484-90. PubMed ID: 8914121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
    Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
    Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys.
    Adams BW; Bradberry CW; Moghaddam B
    Synapse; 2002 Jan; 43(1):12-8. PubMed ID: 11746729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine.
    Takahata R; Moghaddam B
    Neuropsychopharmacology; 2003 Jun; 28(6):1117-24. PubMed ID: 12700703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT2A receptors.
    Maurel-Remy S; Bervoets K; Millan MJ
    Eur J Pharmacol; 1995 Jul; 280(2):R9-11. PubMed ID: 7589172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel analog of olanzapine linked to sarcosinyl moiety (PGW5) demonstrates high efficacy and good safety profile in mouse models of schizophrenia.
    Gil-Ad I; Portnoy M; Tarasenko I; Bidder M; Kramer M; Taler M; Weizman A
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):425-36. PubMed ID: 24389121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential antipsychotic and extrapyramidal effects of (R,S)-3,4-dicarboxyphenylglycine [(R,S)-3,4-DCPG], a mixed AMPA antagonist/mGluR8 agonist.
    Ossowska K; Pietraszek M; Wardas J; Wolfarth S
    Pol J Pharmacol; 2004; 56(3):295-304. PubMed ID: 15215559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between the glycine transporter 1(GlyT1) inhibitor SSR504734 and psychoactive drugs in mouse motor behaviour.
    Singer P; Feldon J; Yee BK
    Eur Neuropsychopharmacol; 2009 Aug; 19(8):571-80. PubMed ID: 19282154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reassessment of amphetamine- and phencyclidine-induced locomotor hyperactivity as a model of psychosis-like behavior in rats.
    Kusljic S; van den Buuse M; Gogos A
    J Integr Neurosci; 2022 Jan; 21(1):17. PubMed ID: 35164453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antagonism of NMDA receptor-mediated neurotransmission and inhibition of the dopamine reuptake in the neuroendocrine effects of phencyclidine.
    Pechnick RN; Bresee CJ; Poland RE
    Life Sci; 2006 Mar; 78(17):2006-11. PubMed ID: 16288927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia.
    Alberati D; Moreau JL; Lengyel J; Hauser N; Mory R; Borroni E; Pinard E; Knoflach F; Schlotterbeck G; Hainzl D; Wettstein JG
    Neuropharmacology; 2012 Feb; 62(2):1152-61. PubMed ID: 22138164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
    Arvanov VL; Wang RY
    J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.